Kleinfelder's Syndrome - Medical Overview PDF

Document Details

InnocuousWashington

Uploaded by InnocuousWashington

Fairleigh Dickinson University

Tags

Klinefelter syndrome medical conditions genetic disorders human health

Summary

This document provides an overview of Klinefelter syndrome (KS), a genetic disorder affecting males. It details the defining characteristics, prevalence in the population, and potential complications. The text also highlights the treatments and associated risks.

Full Transcript

Kleinfelder’s Syndrome · Definitions: o Klinefelter syndrome (KS), also known as polysomy X, refers to the spectrum of phenotypic and functional abnormalities that result from expression of one or more additional X chromosomes in a phenot...

Kleinfelder’s Syndrome · Definitions: o Klinefelter syndrome (KS), also known as polysomy X, refers to the spectrum of phenotypic and functional abnormalities that result from expression of one or more additional X chromosomes in a phenotypic male. o The most overt phenotypic features of KS are caused by testosterone deficiency and, directly or indirectly, by unsuppressed follicle-stimulating and luteinizing hormone secretions. · Klinefelter syndrome is associated with the potential for delay in three major areas of development: o Physical o Language o Social development. o Tall stature, small testes (i.e., male hypogonadism), development of the breasts (i.e., gynecomastia), and low sperm count (i.e., azoospermia) are common clinical signs. o The severity of clinical manifestations is directly related to the number of additional X chromosomes. o Klinefelter syndrome is named after Dr. Harry Klinefelter, who published a report in 1942 describing nine men who had enlarged breasts, sparse facial and body hair, small testes, and inability to produce sperm. o In 1959, it was learned that these men had one extra X chromosome and an XXY genotype. · Prevalence: o The classic form of KS characterized by a karyotype of 47,XXY is one of the most common genetic disorders known, occurring as frequently as 1 in every 500–1,000 male births. o The 47,XXY genotype is present in 80–90% of all cases of KS. o More than 3,000 males with this condition are born every year in the United States. o There is no racial predilection for this condition. o The prevalence rate is 5–20 times higher in individuals with mental retardation than in the general population. o Miscarriage is common and only 40% of embryos and fetuses with KS survive to full term. o The recurrence rate is not greater than that of the general population. · Significance: o The significance of KS lies primarily in the potential development of chronic illnesses and a variety of troublesome clinical manifestations. o Chronic illnesses for which KS patients are at high risk include diabetes mellitus, systemic lupus erythematosus (SLE), and rheumatoid arthritis (RA). o Klinefelter syndrome patients are also at significantly increased risk for developing a variety of cancers, including testicular and breast cancer. · Slightly more than half of all KS cases are due to maternal non-disjunction, which occurs 75% of the time during the first stage of meiosis and 25% of the time during meiosis II. o The remaining cases are the result of paternal non-disjunction. o An increased risk for autoimmune disorders (e.g., diabetes mellitus, SLE, and RA) is presumably, in part, the result of low serum testosterone levels and high serum estradiol/ testosterone (E/T) ratios. o There is some evidence that androgens protect against autoimmunity, while estrogens promote the phenomenon. o Gynecomastia also presumably results from higher-than-normal E/T ratios. o Azoospermia and infertility are caused by atrophy and fibrosis (i.e., scarring) of the seminiferous tubules. · As described above, the most serious complications are those chronic illnesses that are often associated with KS: o diabetes mellitus (8% of all patients) o SLE o RA o testicular cancer o breast cancer o osteoporosis. o Depression may also be a significant side effect of the Condition. o Despite the numerous potential complications of KS, patients can often expect a normal lifespan · Ideally, testosterone replacement therapy is begun as the child enters puberty. o Treatment with testosterone not only helps to reverse Sexual dysfunction and muscular atrophy but also will reduce the risk for developing language problems and improve psychosocial status. o Furthermore, testosterone treatment has been shown to promote strength and physical endurance; build a more muscular physique; increase sexual desire; improve mood, self-image, and behavior; and protect against premature loss of bone mineral density. o Testosterone treatment will not, however, restore fertility. o Four methods for administration of testosterone are currently available: § parenteral, oral, transdermal, and topical. o Hypogonadism is usually treated with parenteral testosterone (i.e., enanthate or cypionate). · A typical adult dose is 200 mg intramuscularly (IM) delivered in the gluteal area every 3 weeks. o For patients 11–12 years old, 50 mg IM is delivered monthly. o Dose is adjusted according to the patient’s response. o Oral androgen preparations (methyltestosterone and fluoxymesterone) are not as effective as parenteral testosterone and occasionally cause reversible hyperbilirubinemia and jaundice. o Testosterone skin patches are available in two formulations for application to non-genital skin. o Testosterone may be mixed with an adhesive (Testoderm II), with a new patch applied daily to a different site. o This transdermal delivery system leaves a sticky residue but causes minimal skin irritation. o Androderm adheres more closely to the skin but may also cause more skin irritation.

Use Quizgecko on...
Browser
Browser